Quick Takeaways
- Sandra A. Gardiner has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Sandra A. Gardiner and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ADGM | Adagio Medical Holdings, Inc. | Director | 20 Mar 2025 | |||
| ANEB | Anebulo Pharmaceuticals, Inc. | Acting Chief Financial Officer | 02 Mar 2023 | |||
| KRON | Kronos Bio, Inc. | Interim CFO | 15 Sep 2023 | |||
| LHDXQ | Lucira Health, Inc. | Director | 01 Jun 2022 | |||
| NKTR | NEKTAR THERAPEUTICS | Chief Financial Officer | 17 Apr 2023 | |||
| PLSE | Pulse Biosciences, Inc. | CFO & EVP Admin. and Finance | 14 Dec 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|